Doximity, Inc. (DOCS)

NYSE: DOCS · Real-Time Price · USD
57.83
+2.65 (4.80%)
At close: Dec 20, 2024, 4:00 PM
58.50
+0.67 (1.16%)
After-hours: Dec 20, 2024, 7:36 PM EST
4.80%
Market Cap 10.80B
Revenue (ttm) 516.85M
Net Income (ttm) 174.11M
Shares Out 186.69M
EPS (ttm) 0.87
PE Ratio 66.17
Forward PE 50.27
Dividend n/a
Ex-Dividend Date n/a
Volume 7,489,007
Open 54.95
Previous Close 55.18
Day's Range 53.81 - 58.08
52-Week Range 22.96 - 61.75
Beta 1.40
Analysts Hold
Price Target 52.13 (-9.86%)
Earnings Date Feb 6, 2025

About DOCS

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manuf... [Read more]

Sector Healthcare
IPO Date Jun 24, 2021
Employees 827
Stock Exchange NYSE
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2023, Doximity's revenue was $475.42 million, an increase of 13.45% compared to the previous year's $419.05 million. Earnings were $147.58 million, an increase of 30.81%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for DOCS stock is "Hold." The 12-month stock price forecast is $52.13, which is a decrease of -9.86% from the latest price.

Price Target
$52.13
(-9.86% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician...

4 days ago - Business Wire

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Doximity's dominance in digital healthcare is evident with over 80% of U.S. doctors using the platform, driving strong network effects and competitive positioning. The company boasts impressive financ...

15 days ago - Seeking Alpha

Doximity Q2 Earnings: Positioning Is Paying Off

I rate Doximity a buy with a price target of $65, reflecting a 24% upside due to strong Q2 earnings and favorable industry trends. Doximity's Q2 earnings showed impressive revenue growth, margin expan...

5 weeks ago - Seeking Alpha

Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday

Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in above what analysts expected.

6 weeks ago - Investopedia

Doximity Stock Soars 42% Toward Best Day Ever. It's Not the Only Record.

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts expectations.

6 weeks ago - Barrons

Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q2 2025 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Perry Gold - Vice President of Investor Relations Jeff Tangney - Co-Founder and CEO Anna B...

6 weeks ago - Seeking Alpha

Doximity Announces Fiscal 2025 Second Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, ...

6 weeks ago - Business Wire

Doximity to Present at the Jefferies London Healthcare Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Nate Gross, co-founder and chief strategy officer, and An...

7 weeks ago - Business Wire

Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ...

2 months ago - Business Wire

Overlooked Stock: DOCS

Doximity (DOCS) is trading near its 52-week high after getting an upgrade from Barclays. George Tsilis talks about why the "LinkedIn for physicians" can be gaining investor interest.

2 months ago - Schwab Network

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. ...

2 months ago - Business Wire

Top 4 Health Care Stocks That May Keep You Up At Night

As of Sept. 24, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Other symbols: BFRGGILDGNFT
3 months ago - Benzinga

Reconsidering Doximity Shares: Should Investors Bet On A Sustained Revenue Growth Inflection

Doximity's guidance in no way reflects the positive tea leaves management discussed during the conference call. Doximity reported better than expected Q1 results with revenues of $127 million and adju...

4 months ago - Seeking Alpha

Doximity: Q1 Earnings Mark A Possible Turnaround For The Company (Rating Upgrade)

Doximity reported strong Q1 FY25 earnings with revenue and Adjusted EBITDA growing 17% and 41% YoY respectively, beating estimates. It saw a 16% increase in customer count in its $500K+ Subscription r...

4 months ago - Seeking Alpha

Doximity Stock Jumps 31%. Here's Why.

The medical platform's quarterly result beat expectations on both top and bottom lines, and is also leveraging AI to appeal to customers.

4 months ago - Barrons

Doximity, Inc. (DOCS) Q1 2025 Earnings Call Transcript

Start Time: 17:00 January 1, 0000 5:50 PM ET Doximity, Inc. (NYSE:DOCS) Q1 2025 Earnings Conference Call August 08, 2024, 17:00 PM ET Company Participants Jeff Tangney - Co-founder and CEO Nate Gross...

4 months ago - Seeking Alpha

Doximity Announces Fiscal 2025 First Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024. ...

4 months ago - Business Wire

Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...

5 months ago - Business Wire

DOCS Investors Have Opportunity to Join Doximity, Inc. Securities Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--DOCS Investors Have Opportunity to Join Doximity, Inc. Securities Fraud Investigation with the Schall Law Firm.

6 months ago - Business Wire

Rosen Law Firm Urges Doximity, Inc. (DOCS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between February 9, 2022 and April 1, 2024. Doximity des...

6 months ago - Business Wire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: ...

6 months ago - GlobeNewsWire

The Schall Law Firm Urges Investors Who Have Suffered Losses With Doximity, Inc. To Make Contact. Please Keep In Mind The Deadline For This Matter

LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "th...

6 months ago - Accesswire

The Schall Law Firm Encourages Investors Who Have Incurred Losses With Doximity, Inc. To Reach Out. Please Be Conscious Of The Time Limit In This Issue

LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...

6 months ago - Accesswire

The Schall Law Firm Urges Investors Who Have Suffered Losses In Doximity, Inc. To Make Contact. Please Be Mindful Of The Deadline For This Matter

LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...

7 months ago - Accesswire

The Schall Law Firm Encourages Investors Who Experienced Losses With Doximity, Inc. To Get In Touch. Please Remember The Deadline For This Issue

LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the...

7 months ago - Accesswire